The Readout Loud

336 Episodes

1. Episode 175: Dorit Reiss on vaccine mandates, plus biotech's messy summer

   Published: 8/26/2021
2. Episode 174: Biotech's trust issues, overwhelmed health workers, & the nuances of insider trading

   Published: 8/19/2021
3. Episode 173: Biden's drug pricing plan, Wall Street's Alzheimer's fixation, & daily 5 a.m. alarms

   Published: 8/12/2021
4. Episode 172: The mRNA gold rush, Delta's alarming rise, & the next treatment for Alzheimer's

   Published: 8/5/2021
5. Episode 171: The quest for a Covid pill, a microbiome gut-check, & CRISPR on the big screen

   Published: 7/29/2021
6. Episode 170: Céline Gounder on breakthrough infections, plus the power of lobbying

   Published: 7/22/2021
7. Episode 169: Dan Diamond on covering Biden, plus the FDA's future, & the latest Aduhelm twist

   Published: 7/15/2021
8. Episode 168: Aduhelm's latest twist, & how Covid variants are shaping the summer

   Published: 7/8/2021
9. Episode 167: George Yancopoulos on biotech in 2021, plus a CRISPR milestone, Biogen's FDA saga,

   Published: 7/1/2021
10. Episode 166: FDA inner workings, GSK's foggy future, & the alarming rise in colorectal cancer

    Published: 6/24/2021
11. Episode 165: Paul Offit on the Covid vaccine booster debate, & Robyn Karnauskas' call of the decade

    Published: 6/17/2021
12. Episode 164: Every angle on the FDA's polarizing approval of Biogen's Alzheimer's drug

    Published: 6/10/2021
13. Episode 163: Marilynn Marchione on covering the CRISPR babies scandal

    Published: 6/3/2021
14. Episode 162: Scott Gottlieb on Covid and grilling, plus how Zolgensma has changed SMA

    Published: 5/27/2021
15. Episode 161: Biotech meme stocks, the lessons of Spanish Flu, & becoming a pandemic celebrity

    Published: 5/20/2021
16. Episode 160: Global Covid-19 failures, a sluggish CDC, and a boisterous STAT Health Tech Summit

    Published: 5/13/2021
17. Episode 159: Thomas Bollyky on patent waivers, plus vaccine riches, & a gene therapy for aging

    Published: 5/6/2021
18. Episode 158: Angela Rasmussen on Russia's vaccine controversy, plus Biden's drug pricing punt

    Published: 4/29/2021
19. Episode 157: Mercedes Carnethon on outdoor masking, FDA in limbo, & gene therapy's uncertain upside

    Published: 4/22/2021
20. Episode 156: J&J's vaccine pause, talking about remote risks, & why no new drugs for Covid-19

    Published: 4/15/2021